Bayer data for kidney disease hope finerenone sets up filing...

Bayer’s blockbuster ambitions for diabetic kidney disease (DKD) drug candidate finerenone look a lot firmer with the publication of data from the phase 3 FIDELIO-DKD trial.

Novo launches type 2 diabetes pill in UK after NICE waives r...

Novo Nordisk has launched its type 2 diabetes pill Rybelsus (semaglutide) in the UK, after cost-effectiveness watchdog NICE decided that there was no need to review it.

NHS backs free behavioural change app for type 2 diabetics

NHS England has awarded a contract to tech company Changing Health to develop a free app to help the millions of people with type 2 diabetes in the UK manage their illness.

FDA fast-tracks Lilly/Boehringer’s Jardiance in chronic kidn...

Lilly, Boehringer bag FDA okay for diabetes triple Trijardy ...

AZ’s Forxiga gets heart claim data on its EU label